Vilas-Boas Filipe, Ribeiro Tiago, Macedo Guilherme, Dhar Jahnvi, Samanta Jayanta, Sina Sokol, Manfrin Erminia, Facciorusso Antonio, Conti Bellocchi Maria Cristina, De Pretis Nicolò, Frulloni Luca, Crinò Stefano Francesco
Gastroenterology Department, Centro Hospitalar e Universitário de São João, Faculdade de Medicina da Universidade do Porto, 4200-349 Porto, Portugal.
Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Diagnostics (Basel). 2024 Jul 23;14(15):1587. doi: 10.3390/diagnostics14151587.
Pancreatic cystic lesions (PCLs) pose a diagnostic challenge due to their increasing incidence and the limitations of cross-sectional imaging and endoscopic-ultrasound-guided fine-needle aspiration (EUS-FNA). EUS-guided through the needle biopsy (EUS-TTNB) has emerged as a promising tool for improving the accuracy of cyst type determination and neoplastic risk stratification. EUS-TTNB demonstrates superior diagnostic performance over EUS-FNA, providing critical preoperative information that can significantly influence patient management and reduce unnecessary surgeries. However, the procedure has risks, with an overall adverse event rate of approximately 9%. Preventive measures and further prospective studies are essential to optimize its safety and efficacy. This review highlights the potential of EUS-TTNB to enhance the diagnostic and management approaches for patients with PCLs. It examines the current state of EUS-TTNB, including available devices, indications, procedural techniques, specimen handling, diagnostic yield, clinical impact, and associated adverse events.
胰腺囊性病变(PCLs)因其发病率不断上升以及横断面成像和内镜超声引导下细针穿刺活检(EUS-FNA)的局限性而带来诊断挑战。超声内镜引导下经针活检(EUS-TTNB)已成为一种有前景的工具,可提高囊肿类型判定和肿瘤风险分层的准确性。EUS-TTNB显示出优于EUS-FNA的诊断性能,提供关键的术前信息,可显著影响患者管理并减少不必要的手术。然而,该操作存在风险,总体不良事件发生率约为9%。预防措施和进一步的前瞻性研究对于优化其安全性和有效性至关重要。本综述强调了EUS-TTNB在增强PCLs患者诊断和管理方法方面的潜力。它审视了EUS-TTNB的当前状况,包括可用设备、适应证、操作技术、标本处理、诊断率、临床影响及相关不良事件。